Risperidona: avaliação de processos administrativos de dispensação no município de Fortaleza, Ceará

Abstract

In 2009, the State of Ceará stipulated a complementary list called the Secondary Pharmaceutical Care Policy, consisting of 40 drugs, which should meet the need for dispensing for the population affected by clinical conditions discovered by other components of pharmaceutical care. Risperidone is one of the most important drugs in this list, due to its extensive use for a wide range of mental health problems. Through this policy, a dispensing regulation was formulated in the city of Fortaleza to guarantee access and reduce the legalization of the medicine. In order to have access to risperidone in the city of Fortaleza, through the cast of secondary pharmaceutical care, the patient must open an administrative process. After opening the process will be evaluated, being approved or rejected. This is a descriptive study with a retrospective design, from January 2021 to December 2022, based on data extracted from a spreadsheet with data from administrative processes requesting risperidone registered in the judicial sector of the Coordination of Pharmaceutical Assistance of the Municipality from Fortaleza, Ceará. The data analyzed showed that 1386 administrative processes for risperidone were filed in 2021 and 2205 in 2022. In the year 2021, 1202 (86.72%) of these processes were granted, 178 (12.84%) were rejected and for 6 (0 .43%) no responses were assigned. In the year 2022, 1600 (72.56%) processes were granted, 324 (14.69%) were rejected, 262 (11.88%) did not have a response designation and 19 (0.86%) were assigned to the CEAF. The average response time for processes in 2021 was 17.96 business days and in 2022 it was 12.44 business days. The highest number of openings of risperidone administrative proceedings in 2021 originated from regional V (26.98%), while in 2022, it was from regional VI (25.48%). Most patient prescriptions at the opening of processes came from the UAPS. The reference unit with the most patients referred for dispensing risperidone was UAPS Anastácio Magalhães, with 136 assignments, in 2021. In 2022, it was UAPS Messejana, with 239 patients assigned. The most requested concentration of risperidone in 2021 was 1mg and in 2022 1mg/ml. In both 2021 and 2022, the most observed ICDs were related to hyperkinetic disorders and conduct disorders. Administrative processes are essential instruments for access to risperidone in the city of Fortaleza, but in order to develop better tools for evaluating administrative processes and guarantee rational access to risperidone, changes focused on the aspects raised by this study will be necessary.